Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MacuLogix
company
About
MacuLogix focuses on detecting and tracking age-related macular degeneration.
- 51 - 100
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $10M
- Industries
- Health Care,Health Diagnostics,Therapeutics
- Founded date
- Jan 1, 2004
- Number Of Employee
- 51 - 100
- Operating Status
- Active
MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
MacuLogix has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Jul 18, 2018 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 18, 2018 | Debt Financing | $10M | 1 |
Horizon Technology Finance
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
MacuLogix is funded by 1 investors.
Horizon Technology Finance
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Horizon Technology Finance
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
